Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Hold
11,412
0.21% 88
2026
Q1
$320K Hold
11,412
0.26% 77
2025
Q4
$284K Hold
11,412
0.22% 84
2025
Q3
$291K Sell
11,412
-612
-5% -$15.1K 0.22% 85
2025
Q2
$291K Sell
12,024
-340
-3% -$7.93K 0.23% 86
2025
Q1
$313K Sell
12,364
-889
-7% -$23.3K 0.27% 81
2024
Q4
$352K Buy
+13,253
New +$359K 0.3% 76

Other funds holding PFE

Finward Bancorp's PFE Position: Q2 2026 in Review

Finward Bancorp held its Pfizer (PFE) position steady in Q2 2026 at 11,412 shares worth $275K. The position accounts for 0.21% of the portfolio, ranked #88.

Finward Bancorp first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $352K in Q4 2024. 672 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Finward Bancorp held 11,412 shares of Pfizer worth $275K as of Q2 2026.
  • Finward Bancorp left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.21% of Finward Bancorp's portfolio in Q2 2026, its #88 holding.
  • Finward Bancorp first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Finward Bancorp's Pfizer position peaked at $352K in Q4 2024.
  • 672 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Finward Bancorp's 13F filing for Q2 2026, filed 16 Jul 2026.